Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

IMMX Immix Biopharma Inc

2,06

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:00:03

Verzögert um 15 Minuten

Form D - Notice of Exempt Offering of Securities

Immix Biopharma (NASDAQ:IMMX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Immix Biopharma Charts.

Immix Biopharma (NASDAQ:IMMX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Immix Biopharma Charts.

News Immix Biopharma Inc

Form 8-K - Current report
Freitag 14 Juni 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 10 Juni 2024 (7 Tage vor) • Edgar (US Regulatory)

RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
Montag 10 Juni 2024 (7 Tage vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Dienstag 21 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 20 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Montag 20 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 20 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 20 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 20 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 20 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Weitere Immix Biopharma Inc News-Artikel

JP Morgan Chase

BNP Paribas (QX)

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen